GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BSP:BMYB34) » Definitions » Cyclically Adjusted PS Ratio

Bristol-Myers Squibb Co (BSP:BMYB34) Cyclically Adjusted PS Ratio : 2.38 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Bristol-Myers Squibb Co's current share price is R$213.69. Bristol-Myers Squibb Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was R$89.80. Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio for today is 2.38.

The historical rank and industry rank for Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:BMYB34' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.21   Med: 4.69   Max: 7
Current: 2.21

During the past years, Bristol-Myers Squibb Co's highest Cyclically Adjusted PS Ratio was 7.00. The lowest was 2.21. And the median was 4.69.

BSP:BMYB34's Cyclically Adjusted PS Ratio is ranked worse than
51.95% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.11 vs BSP:BMYB34: 2.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted revenue per share data for the three months ended in Mar. 2024 was R$29.207. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$89.80 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.10 4.67 4.21 4.34 2.85

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.05 3.65 3.25 2.85 2.91

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio falls into.



Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=213.69/89.8
=2.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=29.207/131.7762*131.7762
=29.207

Current CPI (Mar. 2024) = 131.7762.

Bristol-Myers Squibb Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 5.210 100.560 6.827
201409 5.489 100.428 7.202
201412 6.712 99.070 8.928
201503 7.574 99.621 10.019
201506 7.771 100.684 10.171
201509 9.465 100.392 12.424
201512 9.874 99.792 13.039
201603 9.665 100.470 12.677
201606 9.932 101.688 12.871
201609 9.537 101.861 12.338
201612 10.449 101.863 13.518
201703 9.225 102.862 11.818
201706 10.274 103.349 13.100
201709 10.005 104.136 12.661
201712 10.928 104.011 13.845
201803 10.383 105.290 12.995
201806 13.148 106.317 16.297
201809 14.293 106.507 17.684
201812 14.170 105.998 17.616
201903 13.889 107.251 17.065
201906 14.775 108.070 18.016
201909 15.144 108.329 18.422
201912 16.809 108.420 20.430
202003 23.330 108.902 28.230
202006 23.223 108.767 28.136
202009 24.854 109.815 29.824
202012 25.285 109.897 30.319
202103 27.549 111.754 32.485
202106 26.132 114.631 30.040
202109 27.358 115.734 31.150
202112 30.515 117.630 34.185
202203 26.786 121.301 29.099
202206 27.921 125.017 29.431
202209 27.385 125.227 28.817
202212 28.195 125.222 29.671
202303 27.946 127.348 28.918
202306 25.922 128.729 26.536
202309 26.239 129.860 26.626
202312 27.661 129.419 28.165
202403 29.207 131.776 29.207

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (BSP:BMYB34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (BSP:BMYB34) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (BSP:BMYB34) Headlines

No Headlines